Abstract:Objective To determine whether curcumin synergizes with doxorubicin hydrochloride to induce the death of autophagic cellsand promote doxorubicin hydrochloride-induced apoptosis in 4T1breast cancer cells. Methods The 4T1 mouse breast cancer cell line was used as the study object.The mice were divided into a control group（PBS）, a curcumin group(10 μmol·L -1 curcumin), a doxorubicin hydrochloride group(10 μmol·L -1 doxorubicin hydrochloride), and a combination group(10 μmol·L -1 curcumin + 10 μmol·L -1 doxorubicin hydrochloride). The cytotoxicity of different treatments to 4T1 cells was compared with CCK-8 assay. Apoptosis induced by different treatments was detected with apoptosis detection kit. CCK-8 assay and autophagy inhibition strategy [co-treatment with 3-methyladenosine（3MA）] were used to determine the induction of autophagic cell death. Immunofluorescence technology was used to study the expression of autophagy-related proteins（LC3 and P62） and immunogenic death-related proteins（CRT and HMGB 1） in different treatment groups. To evaluate the extent of immunogenic cell death, ATP secretion of 4T1 cells in different groups was investigated with the ATP assay kit. The effect of different treatments on the phagocytosis and uptake of the dying tumor cells by bone marrow-derived macrophages（BMDCs）and the effect on MCH-Ⅱ expression of BMDCs were determined by flow cytometry. Results CCK-8 showed that curcumin did not obviously induce the cytotoxicity and apoptosis, but the combination of curcumin with doxorubicin hydrochloride significantly enhanced the level of cytotoxicity and cell apoptosis compared with that of doxorubicin hydrochloride alone. After co-incubation with autophagy inhibitor 3MA, the synergistic effect in the combination group disappeared and the cytotoxicity declined. Compared with the control group, the LC3 expression level was significantly increased and the P62 expression was decreased significantly in the combination group. The immunofluorescence showed that curcumin treatment failed to induce the death of immunogenic cells. The CRT expression and HMGB1 release in the doxorubicin hydrochloride group and the combination group were not significantly different, but the level of ATP release was significantly increased in the combined application group. The flow cytometic results showed that the 4T1 cells in the combined application group were engulfed more by BMDCs compared with in the doxorubicin hydrochloride group,and significantly induced more MCH-Ⅱ expression on the surface of BMDCs. Conclusion The synergistic effect of curcumin and doxorubicin hydrochloride is related to the induction of apoptosis of autophagic cells, which promotes the release of ATP from dying tumor cells, and enhances the phagocytic uptake of dying tumor cells by BMDCs.

Curcumin Reverses Doxorubicin Resistance Via Inhibition the Efflux Function of ABCB4 in Doxorubicin‑resistant Breast Cancer Cells.

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin

Curcumin Suppresses Doxorubicin-Induced Epithelial–Mesenchymal Transition Via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells

Curcumin Reverses Chemoresistance of Human Gastric Cancer Cells by Downregulating the NF-κB Transcription Factor

Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.

Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum

Curcumin Induces Cell Death And Restores Tamoxifen Sensitivity In The Antiestrogen-Resistant Breast Cancer Cell Lines Mcf-7/Lcc2 And Mcf-7/Lcc9

Curcumin Increases MDR1 Expression in Breast Cancer MCF-7 and MCF-7/DOX Cells Through Regulating Histone Acetylation

Curcumin Prevents Induced Drug Resistance: A Novel Function?

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells

Liposomal Curcumin Alters Chemosensitivity of Breast Cancer Cells to Adriamycin Via Regulating Microrna Expression.

Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.

Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.

Nrf2 is a Key Factor in the Reversal Effect of Curcumin on Multidrug Resistance in the HCT‑8/5‑Fu Human Colorectal Cancer Cell Line

Synergistic antitumor effect of curcumin combined with doxorubicin hydrochloride on breast cancer cells and related mechanism

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance Through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type P53 Multidrug-resistant Breast Cancer Cells

Liposomal Codelivery of Doxorubicin and Curcumin Sensitizes Antitumor Activity and Reduces Tumor Metastasis

Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butyl Cyanoacrylate) Nanoparticles.

Curcumin Reverses Oxaliplatin Resistance in Human Colorectal Cancer Via Regulation of TGF-β/Smad2/3 Signaling Pathway

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells